
Loading, please wait...

Loading, please wait...

Maintaining genomic stability is vital for reproductive success. Recent studies reveal that DNA damage repair oogenesis depends heavily on Replication Protein A1 (RPA1). This protein acts as the largest subunit of the RPA complex. When researchers inactivate RPA1, the entire complex disassembles. Consequently, oocytes accumulate severe DNA damage that prevents healthy development.
To understand this process, scientists used germline-specific Cre drivers to deplete RPA1 in mammalian models. This loss triggers several canonical pathways. For instance, sensors like ATM and ATR become highly active. Furthermore, p53 and DNA-PK signal a robust response to the accumulated damage. Without functional RPA1, the oocyte cannot mend its genetic material. Therefore, the cell enters a state of genomic instability that halts normal maturation.
Beyond initial repairs, RPA deficiency impacts chromosomal behavior. It leads to significant misalignment during metaphase I and metaphase II. Moreover, altered transcript levels affect the cytoskeleton organization. This disruption impairs folliculogenesis and reduces the total oocyte pool. Ultimately, the lack of RPA1 causes female infertility. This discovery highlights a previously unrecognized role for RPA in mammalian reproductive health and may offer new insights into clinical cases of idiopathic infertility.
RPA1 is the primary subunit of the RPA complex, which binds to single-stranded DNA. It is essential for repairing DNA breaks that occur during oogenesis. Without it, oocytes cannot maintain their genetic integrity.
RPA1 deficiency leads to the disassembly of the RPA complex. This results in severe DNA damage, activation of cellular stress pathways like p53, and chromosome misalignment, which eventually causes infertility.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Miao X et al. Replication Protein A1 is essential for DNA damage repair during mammalian oogenesis†. Biol Reprod. 2026 Feb 27. doi: undefined. PMID: 41757504.
Zhang L et al. Molecular regulation of DNA damage and repair in female infertility: a systematic review. J Assist Reprod Genet. 2024 Aug 14. doi: 10.1007/s10815-024-03214-7.
Ruggeri E et al. Identification and Preliminary Analysis of Granulosa Cell Biomarkers to Predict Oocyte In Vitro Maturation Outcome. Cells. 2024 Dec;13(24):2024.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies Replication Protein A1 (RPA1) as a critical factor in DNA repair during oogenesis, linking its loss to infertility and chromosome is...
6 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today